Estrogen priming modulates autoreceptor-mediated potentiation of dopamine uptake

European Journal of Pharmacology

Volumn 401, Issue 3, 2000, Pages 357-363

  Thompson, Tina L ^a   Moore, Christopher C ^a   Smith, Brian ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine D2 receptor agonist; Dopamine D2 receptor antagonist; Protein phosphatase; Steroid; Uptake

Indexed keywords

AUTORECEPTOR; CANTHARIDIN; CIPERMETHRIN; DELTAMETHRIN; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ESTRADIOL BENZOATE; ESTROGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR POTENTIAL;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; AUTORECEPTORS; BIOLOGICAL TRANSPORT; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESTROGENS; FEMALE; HALOPERIDOL; KINETICS; OVARIECTOMY; PHOSPHOPROTEIN PHOSPHATASE; PYRANS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SPIRO COMPOUNDS; SYNAPTOSOMES; TIME FACTORS;

EID: 0034637369     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00432-5     Document Type: Article

References (30)

1. Attali G., Weizman A., Gil-Ad I., Rehavi M. Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters. Brain Res. 756:1997;153-159.
2. Batchelor M., Schenk J.O. Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J. Neurosci. 18:1998;10304-10309.
3. 2 dopamine receptors can modulate dopamine uptake. Neurosci. Lett. 176:1994;259-263.
4. Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev. Neurosci. 5:1994;27-42.
5. Di Paolo T., Falardeau P., Morissette M. Striatal dopamine agonist binding sites fluctuate during the rat estrous cycle. Life Sci. 43:1988;665-672.
6. Enan E., Matsumura F. Specific inhibition of calcineurin by type II synthetic pyrethroid insecticides. Biochem. Pharmacol. 43:1992;1777-1784.
7. Fischer H., Illek B., Machen T. Regulation of CFTR by protein phosphatase 2B and protein kinase C. Eur. J. Physiol. 436:1998;175-181.
8. Garris P., Wightman R.M. Regional differences in dopamine release, uptake and diffusion measured by fast-scan cyclic voltammetry. Boulton A.A., Baker G.B., Adams R.N. Neuromethods: Voltammetric Methods in Brain Systems. 1995;179-220 Humana Press, Totowa, NY.
9. Giros B., Caron M.G. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14:1993;43-49.
10. Gong M.C., Cohen P., Kitazawa T., Ikebe M., Masuo M., Somlyo A.P., Somiyo A.V. Myosin light chain phosphatase activities and the effects of phosphatase inhibitors in tonic and phasic smooth muscle. J. Biol. Chem. 267:1992;14552-14668.
11. 3 receptor. J. Neural Transm. 103:1996;1163-1175.
12. Hitri A., Hurd Y.L., Wyatt R.J., Deutsch S.I. Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance. Clin. Neuropharmacol. 17:1994;1-22.
13. Horn A.S. Dopamine uptake: a review of progress in the last decade. Prog. Neurobiol. 43:1990;387-400.
14. max. J. Neurochem. 68:1997;225-232.
15. 2-dopamine-autoreceptors. Br. J. Pharmacol. 122:1997;1561-1566.
16. Jarvie K.R., Tiberi M., Caron M.G. Dopamine receptors and transporters. Niznik H.B. Pharmacology, Structure and Function. 1994;133-150 Marcel Dekker, New York.
17. Kitayama S., Dohi T., Uhl G. Phorbol esters alter functions of the expressed dopamine transporter. Eur. J. Pharmacol. 268:1994;115-119.
18. Levesque D., Di Paolo T. Modulation by estradiol and progesterone of the GTP effect on striatal D-2 dopamine receptors. Biochem. Pharmacol. 45:1993;723-733.
19. 2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61:1993;764-767.
20. Milligan G., Bond R.A., Lee M. Inverse agonism: pharmacological curiosity or potential therapeutic strategy? TIPS. 16:1995;10-13.
21. Morissette M., Di Paolo T. Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites. J. Neurochem. 60:1993;1876-1883.
22. Morissette M., Di Paolo T. Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology. 58:1993;16-22.
23. 2 antagonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine. J. Neurochem. 60:1993;376-379.
24. Reith M.E.A., Xu C., Chen N-H. Pharmacology and regulation of the neuronal dopamine transporter. Eur. J. Pharmacol. 324:1997;1-10.
25. Salah R.S., Kuhn D.M., Galloway M.P. Dopamine autoreceptors modulate the phosphorylation of tyrosine hydroxylase in rat striatal slices. J. Neurochem. 52:1989;1517-1522.
26. Thompson T.L. Attenuation of dopamine uptake in vivo following priming with estradiol benzoate. Brain Res. 834:1999;164-167.
27. Thompson T.L., Moss R.L. Estrogen regulation of dopamine release in the nucleus accumbens: genomic- and nongenomic-mediated effects. J. Neurochem. 62:1994;1750-1756.
28. Thompson T.L., Moss R.L. Modulation of mesolimbic dopaminergic activity over the estrous cycle. Neurosci. Lett. 229:1997;145-148.
29. Zhang L., Coffey L.L., Reith M. Regulation of the functional activity of the human dopamine transporter by protein kinase C. Biochem. Pharmacol. 53:1997;677-688.
30. Vaughan R.A., Huff R.A., Uhl G.R., Kuhar M.J. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272:1997;15541-15546.